Drug Discovery Software For Pre-Clinical
-
by Qynapsebased in FRANCE
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier precision on the frontlines of CNS disease. QyScore is intended for automatic labeling, visualization and volumetric quantification of segmentable brain ...
-
based in USA
While much traditional protein modeling software takes a pure first-principles approach using deep expert knowledge of physics and chemistry, and modern AI tools often take a model-free approach based entirely on data, the Rosetta software package takes a combined approach based on physics and on statistical patterns. This combination, along with a relentless focus on the prediction of ...
-
by VeriSIM Lifebased in USA
BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illness or disease. ...
-
based in NETHERLANDS
Capture the full acoustic spectrum to process and analyze rodent ultrasonic calls and other animal ...
-
by Certarabased in USA
Biological medicines (“biologics” or “large molecule drugs”) now account for 30% of new drug approvals and up to 50% of the pharmaceutical industry’s pipeline. Biologics differ from small molecules because they are much larger, have slower absorption rates, confined distribution, and different elimination. They are designed for a specific target, typically found on ...
-
by InterXbased in USA
InterX Development Division focuses on bridging the risk gap in Drug Discovery from drug targets to novel candidates. The Development Division applies InterX’s proprietary computer-aided drug design platform, while developing collaborations with Research Centers, Pharma companies, Start-ups, Academia and Accelerators. Such collaborations help distill the drug discovery process – from ...
-
by Instem Groupbased in UNITED KINGDOM
We believe results are what matter and what makes ALPHADAS and the Instem Clinical team unique. We care about the commitment and investment our clients make in choosing ALPHADAS as their system of choice to streamline their clinical operations and we want them to see a Day 1 Return on Investment. Our early phase expertise is second to none and with more than 100 years of hands-on, practical ...
-
Manufactured by Intelligencebased in GERMANY
Ontosight Explore enables the exploration, detection and building of various direct and in-direct connections between drug, target, pathway and disease. We leverage a biological network model using enhanced natural language processing, statistical scoring approach and entity normalization. Our self learning, life science ontology, has more than 20 million concepts and terms and brings together ...
-
Manufactured by Intelligencebased in GERMANY
The clinical trial prediction (CTP) engine empowers your decision-making: Predict the probability of clinical trial success, Evaluate-investment-decisions, Track clinical trial KPIs and identify critical path. Leverage AI to predict clinical trial outcomes: There are a lot of statistics about drug development – and all of them show that the process is inefficient and expensive: Pharma ...
-
based in USA
CompuDrug´s PrologD calculates a good estimation for the "true" value of logD, which characterizes compounds with dissociable groups, i.e. practically all of the structures, which you will encounter in medicinal chemistry. The calculation accounts for all possible interactions of the dissociable groups by an approach developed by the authors of the software and published (J. Pharm. Sci., ...
-
by Acellerabased in UNITED KINGDOM
PlayMolecule is our platform for computable drug discovery where algorithms, data and computers integrate to discover new ...
-
by CRScube Inc.based in SOUTH KOREA
Pharmacovigilance requires a lot of resources such as personnel, processes, and management systems. cubeSAFETY® streamlines the Pharmacovigilance Reporting process; all the while being compliant with the regulations of regulatory agencies such as the FDA, EMA, CDE, MFDS, and ...
-
by Cypre, Inc.based in USA
Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. Cypre Panels rapidly screen small molecules, biologics and cell therapy in 3D hydrogel in vitro tumor models. ...
-
Manufactured by Intelligencebased in GERMANY
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...
-
by Qlucore ABbased in SWEDEN
The combination of powerful statistics and instant visualization drives exciting results. Flexibility and expansion are cornerstones. Analyze data using an easy to use statistical model. Integrate and extend the analysis with Python based Templates for scripting. Add statistical methods through the Open API to R. Filter on genomic entities such as read coverage and variants with the NGS module. ...
-
Manufactured by Agilent Technologies, Inc.based in USA
The SureSelect Focused Exome is a highly targeted design that enables analysis of only the disease-associated targets providing deep coverage even on a benchtop sequencer. This design provides 20 or more reads for 95% of targets at 1.5Gb (100x) of sequencing and 98% of targets with 3Gb (200x) of sequencing enabling superior coverage of disease-associated regions even when sequenced on benchtop ...
-
by PathAI, Inc.based in USA
AISightTM is a web-based digital pathology slide viewing platform that enables the management and analysis of whole slide ...
-
based in USA
The Kinase Knowledgebase (KKB) is Eidogen-Sertanty's database of kinase structure-activity and chemical synthesis data. The KKB represents the first gene-family wide implementation of our proprietary web-based technology for the capture, curation, and display of biological activity and chemical synthesis data from scientific literature and ...
-
based in USA
The Oncology Knowledgebase (OKB) is Eidogen-Sertanty's database of structure-activity data across numerous targets of oncological interest. Nicely complementing the Kinase Knowledgebase (KKB), the OKB will cover a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, Melanoma, Ovarian ...
-
based in CAMBODIA
Qdata™ by Verana Health are disease-specific, fit-for-purpose data modules designed to confidently drive business insights and rigorously inform research outcomes. Qdata spans three therapeutic areas-ophthalmology, neurology, and urology—and reflects deep patient journeys across robust demographics. Qdata helps to unlock quality research insights along the entire drug and medical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you